Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1091 | 984 | 1264 | 1071 | 1373 | 1680 |
Fund Return | 9.08% | -1.65% | 26.4% | 2.32% | 6.54% | 5.33% |
Place in category | 182 | 500 | 57 | 211 | 208 | 123 |
% in Category | 23 | 75 | 7 | 37 | 33 | 35 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pax Global Environmental Mrkts Inst | 2.21B | 8.72 | 0.73 | 8.67 | ||
Pax Balanced Individual Investor | 1.36B | 7.61 | 1.10 | 6.67 | ||
Pax Large Cap Fund Institutional | 1.31B | 12.73 | 3.92 | - | ||
Pax Balanced Institutional | 958.94M | 7.82 | 1.34 | 6.94 | ||
Pax Small Cap Institutional | 605.18M | 11.74 | -0.44 | 6.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 214.44B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 79.67B | 8.18 | 1.45 | 4.94 | ||
Fidelity International Index Inst | 52.9B | 6.96 | 2.81 | 5.35 | ||
Fidelity Series Global ex US Index | 48.18B | 8.52 | 1.64 | 4.77 | ||
Vanguard Total Intl Stock Index I | 43.79B | 8.23 | 1.49 | 4.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 2.64 | 10,176.0 | +1.86% | |
Novartis | CH0012005267 | 2.59 | 92.03 | -0.36% | |
Novo Nordisk B | DK0062498333 | 2.55 | 748.3 | -0.08% | |
Schneider Electric | FR0000121972 | 2.22 | 240.25 | +0.67% | |
HSBC | GB0005405286 | 2.21 | 698.60 | +0.68% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review